Institutional Ownership
Krystal Biotech Inc
CUSIP 501147102COMKRYSQ1 2026
13D / 13G Filings
40
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
14.9%
Max % of class reported
Institutional Holders
359
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
40 filings · latest Feb 5, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2025 | State Street Corporation | 13G | 4.4% | 1.28M | SEC |
| 2 | Nov 14, 2024 | Redmile Group, LLC | 13G/A | 2.8% | 810.2K | SEC |
| 3 | Nov 12, 2024 | Fmr LLC | 13G/A | 14.9% | — | SEC |
| 4 | Oct 16, 2024 | State Street Corp | 13G | 5.1% | 1.45M | SEC |
| 5 | Jul 10, 2024 | Vanguard Group Inc | 13G/A | 10.1% | 2.87M | SEC |
| 6 | Jul 8, 2024 | Blackrock Inc. | 13G/A | 13.8% | 3.95M | SEC |
| 7 | Feb 14, 2024 | Redmile Group, LLC | 13G/A | 6.1% | 1.73M | SEC |
| 8 | Feb 14, 2024 | Avoro Capital Advisors LLC | 13G/A | 9.1% | 2.57M | SEC |
| 9 | Feb 13, 2024 | Vanguard Group Inc | 13G | 8.6% | 2.44M | SEC |
| 10 | Feb 12, 2024 | Fmr LLC | 13G/A | 11.9% | — | SEC |
30 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Krystal Biotech Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 4.37M | $1.13B |
| 2 | Blackrock, Inc. | 3.94M | $1.02B |
| 3 | Avoro Capital Advisors LLC | 2.89M | $746.26M |
| 4 | State Street Corp | 1.31M | $339.54M |
| 5 | Soleus Capital Management, L.P. | 1.15M | $297.87M |
| 6 | Capital World Investors | 824.7K | $213.04M |
| 7 | Redmile Group, LLC | 673.5K | $173.98M |
| 8 | Geode Capital Management, LLC | 644.0K | $166.38M |
| 9 | Hood River Capital Management LLC | 619.6K | $160.05M |
| 10 | Bellevue Group AG | 481.8K | $124.45M |